These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
644 related items for PubMed ID: 28343557
1. Infants Born to Opioid-Dependent Women in Ontario, 2002-2014. Brogly SB, Turner S, Lajkosz K, Davies G, Newman A, Johnson A, Dow K. J Obstet Gynaecol Can; 2017 Mar; 39(3):157-165. PubMed ID: 28343557 [Abstract] [Full Text] [Related]
2. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates. Kelty E, Hulse G. Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981 [Abstract] [Full Text] [Related]
3. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Kakko J, Heilig M, Sarman I. Drug Alcohol Depend; 2008 Jul 01; 96(1-2):69-78. PubMed ID: 18355989 [Abstract] [Full Text] [Related]
4. Use of naltrexone in treating opioid use disorder in pregnancy. Towers CV, Katz E, Weitz B, Visconti K. Am J Obstet Gynecol; 2020 Jan 01; 222(1):83.e1-83.e8. PubMed ID: 31376396 [Abstract] [Full Text] [Related]
5. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome. Winhusen T, Wilder C, Wexelblatt SL, Theobald J, Hall ES, Lewis D, Van Hook J, Marcotte M. Contemp Clin Trials; 2014 Sep 01; 39(1):158-65. PubMed ID: 25183042 [Abstract] [Full Text] [Related]
6. Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population. Jumah NA, Edwards C, Balfour-Boehm J, Loewen K, Dooley J, Gerber Finn L, Kelly L. BMJ Open; 2016 Oct 31; 6(10):e011774. PubMed ID: 27799240 [Abstract] [Full Text] [Related]
7. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. Nechanská B, Mravčík V, Skurtveit S, Lund IO, Gabrhelík R, Engeland A, Handal M. Addiction; 2018 Jul 31; 113(7):1286-1294. PubMed ID: 29443414 [Abstract] [Full Text] [Related]
8. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data. Debelak K, Morrone WR, O'Grady KE, Jones HE. Am J Addict; 2013 Jul 31; 22(3):252-4. PubMed ID: 23617867 [Abstract] [Full Text] [Related]
9. Buprenorphine and naloxone compared with methadone treatment in pregnancy. Wiegand SL, Stringer EM, Stuebe AM, Jones H, Seashore C, Thorp J. Obstet Gynecol; 2015 Feb 31; 125(2):363-368. PubMed ID: 25569005 [Abstract] [Full Text] [Related]
10. Opioid Use Disorder and Perinatal Outcomes. Piske M, Homayra F, Min JE, Zhou H, Marchand C, Mead A, Ng J, Woolner M, Nosyk B. Pediatrics; 2021 Oct 31; 148(4):. PubMed ID: 34479983 [Abstract] [Full Text] [Related]
11. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone. Petrich M, Battin M, Walker E, Brown M, Abdelwahab M, Ma'ayeh M, Rood KM. J Matern Fetal Neonatal Med; 2022 Dec 31; 35(26):10481-10486. PubMed ID: 36202398 [Abstract] [Full Text] [Related]
12. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. O'Connor AB, Collett A, Alto WA, O'Brien LM. J Midwifery Womens Health; 2013 Dec 31; 58(4):383-8. PubMed ID: 23931660 [Abstract] [Full Text] [Related]
13. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison. Unger A, Jagsch R, Jones H, Arria A, Leitich H, Rohrmeister K, Aschauer C, Winklbaur B, Bäwert A, Fischer G. Addiction; 2011 Jul 31; 106(7):1355-62. PubMed ID: 21438938 [Abstract] [Full Text] [Related]
14. Buprenorphine compared with methadone in opioid-dependent pregnant women: How does it affect neonatal abstinence syndrome? Bivin B, Waring A, Alves P. J Am Assoc Nurse Pract; 2019 Dec 04; 33(2):119-125. PubMed ID: 31809398 [Abstract] [Full Text] [Related]
15. Neonatal abstinence syndrome after methadone or buprenorphine exposure. Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Fischer G. N Engl J Med; 2010 Dec 09; 363(24):2320-31. PubMed ID: 21142534 [Abstract] [Full Text] [Related]
16. A population-based time-series analysis of opioid agonist treatment dispensed during pregnancy. Schmidt RA, Everett K, Perez-Brumer A, Strike C, Rush B, Gomes T. Addiction; 2024 Jun 09; 119(6):1111-1122. PubMed ID: 38476027 [Abstract] [Full Text] [Related]
17. Are infants exposed to methadone in utero at an increased risk for mortality? Kelly LE, Rieder MJ, Bridgman-Acker K, Lauwers A, Madadi P, Koren G. J Popul Ther Clin Pharmacol; 2012 Jun 09; 19(2):e160-5. PubMed ID: 22580362 [Abstract] [Full Text] [Related]
18. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women. Tran TH, Griffin BL, Stone RH, Vest KM, Todd TJ. Pharmacotherapy; 2017 Jul 09; 37(7):824-839. PubMed ID: 28543191 [Abstract] [Full Text] [Related]
19. Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure. Nguyen L, Lander LR, O'Grady KE, Marshalek PJ, Schmidt A, Kelly AK, Jones HE. Am J Addict; 2018 Mar 09; 27(2):92-96. PubMed ID: 29473258 [Abstract] [Full Text] [Related]
20. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome. Tolia VN, Murthy K, Bennett MM, Miller ES, Benjamin DK, Smith PB, Clark RH. J Perinatol; 2018 Jan 09; 38(1):75-79. PubMed ID: 29048415 [Abstract] [Full Text] [Related] Page: [Next] [New Search]